(RTTNews) - Achilles Therapeutics plc (ACHL) Thursday announced the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials.
The worst that was feared has been confirmed with Jermaine Johnson. The defender sustained an Achilles injury. Not yet placed ...
The additional funding will be used by Mentor’s K9 operations for training, pet supplies, protective vests, health care and ...
American depositary receipts of Achilles Therapeutics rose 32% after the company disclosed cost-cutting measures as part of a strategic update. ADRs were trading around 94 cents. ADRs are up about 12% ...
Former President Trump's campaign is alarmed by the idea that North Carolina Lt. Gov. Mark Robinson's political baggage and ...
A remembrance service for Mentor K9 Officer Achilles, who passed away due to a sudden medical emergency on Aug. 18, is ...
As of June 30, Achilles Therapeutics said it had $95.1 million in cash and cash equivalents. The company also said it has discontinued its TIL-based cNeT program and closed the phase 1/2a Chiron and ...
The video is a comprehensive guide to Achilles tendinopathy from Professor Peter Malliaras, a physiotherapist who specializes ...
Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...
Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...